CURRICULUM VITAE
May 2020
Robert L. Benz, M.D., F.A.C.P., F.A.S.N.Chief, Division of
Nephrology, Main Line Health Hospitals and Lankenau Medical
CenterProfessor of Medicine, Thomas Jefferson Universitycell:
610-529-3966; email: [email protected]
Mailing Address PO Box 345. Narberth, PA 19072
Clinical Office Address:Nephrology Associates
100 Lancaster Avenue Suite 130 MOB South
Wynnewood, Pennsylvania 19096
Phone (610) 649-ll75FAX # (610) 896-8753
Education:
1970‑1974
B.A. University of Pennsylvania
2 majors: Biology and Foreign Literature - Graduated cum
laude.
1974‑1978
M.D. Jefferson Medical College
Philadelphia, Pennsylvania
Postgraduate Training & Fellowship Appointments:
1978‑1981
Internal Medicine Residency at Lankenau Hospital,
Philadelphia, Pennsylvania
1981‑1983
Fellowship, Nephrology, Lankenau Hospital
Faculty Appointments:
2012-presentProfessor of Medicine, Jefferson Medical College
(now Sidney Kimmel Medical College of Thomas Jefferson
University)
1996- 2012
Clinical Professor of Medicine, Jefferson Medical College
2001- present
Clinical Professor, Lankenau Institute for Medical Research
Special Appointments: (Recent)
1996-present:
Chief, Division of Nephrology, Main Line Heath Hospitals and
Lankenau Medical Center
July 2009-September 2018 (ended due to regionalization of
position):
Vice President of Medical Affairs, Lankenau Medical Center
(Inaugural VPMA)
2012-2018 (ended due to term limit):
Accreditation Council of Graduate Medical Education (ACGME)
Residency Review Committee- Internal Medicine (representing The
American Society of Nephrology and The American College of
Physicians)
2001-2018 (passing the torch):
Program Director, Lankenau Medical Center Nephrology Fellowship
Program
Other Administrative Appointments (Chronology)
Spring, 2020
COVID-19 Virus Pandemic Crisis Standards Committee Triage
Leadership for Main Line Health
2016-2018
Lankenau Diversity and Respect Committee
July 2007- 2018
Chairman Lankenau Hospital Patient Safety & Quality
Committees
July 2010-2018
Co-Chair, Main Line Health Medical Records Committee
Sept 2010-2018
Chair, LMC Nutrition Support Committee
July 2009- 2018
Vice-President Medical Affairs, Lankenau Medical Center
2009-2018
Peer Review Committee Member, Lankenau Medical Center
Sept 2005-2018
Member, Main Line Health Medical Executive Committee and
Lankenau Institute for Medical Research (LIMR) Education &
Research Board
July 2007-July 2009
President, Lankenau Hospital Medical Staff
2005-2006
President, Nephrology Associates
2001-2018
Director of Nephrology Fellowship Program, Lankenau Medical
Center
Sept 2005-2018
Chair, Utilization Management Committee
July 2005-June 2007
Vice-President of Lankenau Hospital Medical Staff
1990- 2007
Member of Lankenau Hospital Institutional Review Board
1996-2007
Vice Chair Lankenau Hospital Institutional Review Board
(IRB)
1990-1996
Program Director, Lankenau Internal Medicine Residency
Program
1996-present
Chief, Division of Nephrology, Main Line Health Hospitals
1983-present
Physician Nephrologist, Nephrology Associates, Lankenau
Hospital
Specialty Certification:
1999
ASH Specialist in Clinical Hypertension
1984
Nephrology
1981
American Board of Internal Medicine (#81592)
Licensure:
Pennsylvania
MD 023238E
Awards, Honors & Membership in Honorary Societies
2020
Top Doctor – Philadelphia Magazine – 18 consecutive years
2019
Top Doctor – Philadelphia Magazine –
2018
Top Doctor – Philadelphia Magazine –2018
Top Doctor –Main Line Today- multiple times2017
Top Doctor – Philadelphia Magazine 2017
Top Doctor –Main Line Today2016
Top Doctor – Philadelphia Magazine2016
2016 National Kidney Foundation Physician of the Year Honoree
for Excellence in Nephrology Clinical Care
2015
Top Doctor – Philadelphia Magazine
2015
Fellow of the American Society of Nephrology - FASN2014
Top Doctor – Philadelphia Magazine2014
Top Doctor – Main Line Today
2013
Top Doctor – Philadelphia Magazine
2012
Top Doctor - U.S News & World Report
2012
SuperDoctors.com – Philadelphia Area
2012
Recognized in “Guide to America’s Top Physicians”
2012
Top Doctor- Best of Philadelphia Magazine- Nephrology
2012
Top Doctor – Consumer’s Report Checkbook
2011
Top Doctor - -U.S News & World Report
2011
Top Doctor- Best of Philadelphia Magazine- Nephrology
2011
Top Doctor – Consumer’s Report Checkbook
2010
Top Doctor- Best of Philadelphia Magazine- Nephrology
2009
Top Doctor – Best of Philadelphia Magazine – Nephrology
2009
Outstanding Contribution Award – Philadelphia College of
Osteopathic Medicine
2008
America’s Top Physicians – Guide to America’s Top Physicians
2008
Top Doctor – Best of Philadelphia Magazine - Nephrology
2007
Top Doctor – Best of Philadelphia Magazine - Nephrology
2007
Top Doctor (Nephrology): Consumers( Guide to Top Doctors:
By the Editors of Consumers( Checkbook Magazine
2006
Top Doctor: Consumers( Guide to Top Doctors: Checkbook
Magazine
2006
Top Doc: Best of Philadelphia Magazine - Nephrology
2005
Top Doc: Best of Philadelphia Magazine - Nephrology
2004
Top Doc: Best of Philadelphia Magazine - Nephrology
2003
Consumers Guide to Top Doctors: by the Editors of Consumers(
Checkbook Magazine
2003
Outstanding Physicians: Delaware Valley Consumers( Checkbook
Magazine of Delaware Valley Area’s Top Doctors; Volume 1 No. 2;
Summer/Fall 2003
2003
National Register’s Who’s Who for Professionals and
Executives
2002
Top Doc: Best of Philadelphia Magazine - Nephrology
2002
Strathmore Who(s Who, Honored Member
2001
Best Teacher Award, Department of Medicine, Lankenau
Hospital
1999
Philadelphia College of Osteopathic Medicine, Outstanding
Contributions Award
1996
American Society of Nephrology Blue Ribbon Award for Abstract:
Predictors of Mortality in ESRD Patients with Sleep Disorders
1996
Marquis Who’s Who, ABMS Directory of Board Certified Medical
Specialists
1991
Fellow, College of Physicians of Philadelphia
1990
Sigma Xi, The Scientific Research Society, Thomas Jefferson
University Chapter.
1990
American Society of Nephrology Travel Award to the XI
International Congress of Nephrology, Tokyo, Japan, July 15-20.
1989
Fellow, American College of Physicians. ACP # 092 090
1981
Nominated for Governor's Award at the Eastern PA American
College of Physicians for presentation of work on "Spontaneous
Platelet Aggregation in Metastatic Adenocarcinoma".
1978
Hare Society
1977
Personal Letter of Commendation from Department of
Psychiatry
Thomas Jefferson Medical College
1976
Personal Letter of Commendation from Department of Pathology
Thomas Jefferson Medical College
1975-1978 Student Council, Jefferson Medical College
Chairman: Faculty Portrait Committee, Jefferson Medical
College
Community Advisory Boards
2006-PresentBoard of Directors, Advisory Board for University of
Pennsylvania Roy Vagelos Life Sciences and Management Program
2009-PresentBoard of Directors, University of Pennsylvania
Alumni Grapplers Club
2006-2011Director, Advisory Board for Educational Foundation of
Lower Merion
Past or Intermittent On-Going Industry Medical Advisory
Boards
1. Amgen (also 10 year Epogen Anniversary Speaker and trained
Product Specialists)
2. Ortho Biotech (J&J) (also worked closely with Janssen and
Cilag); also trained Product Specialists);
and Keynote Clinical Speaker at Launch of Procrit
3. Abbott Pharmaceuticals – Renal Division (Clinical research
and Speaker and Product Specialist trainer and writer for Vitamin D
products and investigational related derivatives)
4. AMAG Pharmaceuticals
5. Hematide (Affymax)
6. Renal Care Group
7. American Society of Artificial Internal Organs
SOCIETY MEMBERSHIPS
1.Fellow, American College of Physicians (092 090)
2.Pennsylvania Kidney Foundation
3.Pennsylvania Medical Society (04102780090)
4.Montgomery County Medical Society (04102780090)
5.Diplomate, American Board of Internal Medicine
6.International Society of Nephrology
7.Diplomate, National Board of Medical Examiners
8.National Kidney Foundation of Southeastern Pennsylvania
9.American Society for Artificial Internal Organs
10.American Society of Hypertension
11.American Heart Association (88024288)
12.American Medical Association (04102780090)
13.American Society of Nephrology (006882)
14.Sigma Xi (909991411)
15.Association for Program Directors in Internal Medicine
(APDIM)
16.Fellow, College of Physicians of Philadelphia
17.Pennsylvania Association of Medical Education
18.Association of Specialty Professors
19.Association of Professors of Medicine
20.Sharpe Foundation Research
21.Renal Physicians Association – Program Committee 2010
AD HOC JOURNAL REVIEWER (date of first review)
2009
Hemodialysis International
2007
Renal Failure Journal
2006
Clinical Journal of American Society of Nephrology
2003-presentKidney International
American Journal of Kidney Disease
Clinical Nephrology
2002
Reviewer, Circulation
1999
Reviewer, American Society of Health - System Pharmacist -
Annual Reviewers for AHFS Drug
Information on Monograph Regarding Sodium Ferric Gluconate
1998
Medical Advisory Board and Editorial Board, Renal Dynamics
1998
Reviewer, Journal of the American Society of Nephrology
1994-1998Editorial Review Board, Osteo-Dynamics
1993-1997Editorial Review Board, Transactions, American Society
of Artificial Internal Organs
1993
Reviewer, American Journal of Kidney Diseases
1992
Reviewer, American Hospital Formulary Services, Monograph on
Erythropoietin
1991
Reviewer, American Society for Artificial Internal Organs
Transactions
1989
Co-Reviewer, C.A.P.D. Abstracts, National Kidney
Foundation/American Society of Nephrology.
1989
Reviewer, Kidney International
PROFESSIONAL EXPERIENCE
2010
American Society of Nephrology, November 2010, Denver CO
Mentor for Recruitment of Residents and Students Interested in
Nephrology Program
2010
National Kidney Foundation Scientific Clinical Meeting, April
2010, FL
Mentor for Recruitment of Residents and Students Interested in
Nephrology Program
2010
Renal Physicians Association (RPA) Program Committee (2011
Meeting)
2009
Vice President Medical Affairs, Lankenau Hospital
2009
Chairman, Lankenau Quality and Safety Committees
2008
President, Lankenau Hospital Medical Staff
2007
President, Lankenau Hospital Medical Staff
2005-2006President, Nephrology Associates
2005-2007Vice-President, Lankenau Medical Staff
2004-2007Lankenau Physician Giving Campaign Co-Chair
1998-2007Vice Chairman, Lankenau Institutional Research Review
Board
2004
Nephrology Coverage Advisory Committee c/o Renal Physicians
Association, Pennsylvania
Representative - New York, NY - October 8th - 9th 2004.
2004
Quality Care Committee for RMS Disease Management Services
2004
Panel Chairman: Predictors of Low Hemoglobin Levels: Are Your
Patients at Risk?
Annual Dialysis Conference (24th Annual Conference on Peritoneal
Dialysis, 10th International
Symposium on Hemodialysis, 15th Annual Symposium on Pediatric
Dialysis), San Antonia TX –
February 10th 2004.
2003-2005Coach of Lankenau Hospital Residents( Medical Jeopardy
Team
2003
The Access Nephrology National Steering Committee, Sponsored by
Genentech
November 7-9, 2003 Miami Florida
2003
Main Line Health CPOE (Computerized Physician Order Entry)
Council
2003
Nephrology Carrier Advisory Panel (nCAP), Sponsored by The Renal
Physicians Association
2003
Network Forum Public-Private Industry Leadership Counsel
2002-2008Lankenau Institute of Medical Research: Director of
Clinical Operations
2001, 2002Coach, American College of Physicians, Lankenau
Jeopardy Team: Eastern Pennsylvania
Regional Champions, Pennsylvania State Runners-Up
2001-2018 Director, Nephrology Fellowship Program, Lankenau
Hospital/Main Line Health
2000-2002National Medical Advisory Board, Renal Care Group,
Inc.
1999
Chairman, Main Line Health Search Committee for Department of
Emergency Medicine
1999
Vice-Chairman, Main Line Health Institutional Review Board,
Lankenau Hospital
1998
Vice-Chairman, Main Line Health Medical Executive Committee
1998
Abstract Review Committee, ASN, Dialysis/Modeling and
Adequacy
1998-Present Chief, Division of Nephrology, Main Line Health
Systems
1998
Member, Medical Advisory Board, National Kidney Foundation of
Southeast PA
1998-2006NIH Co-Chair: Writing and Publications Committees,
Quality of Life HEMO Study - Blood Pressure
1998
Invited Contributor and Reviewer, ABIM Recertification
Examination for Nephrology
1998
Amgen Medical Advisory Board for Nephrology
1997
Advisory Board for Core Curriculum for Dialysis Technicians
(MMA)
1997
Epogen Faculty Program Advisory Committee
1996
Invited Contributor and Reviewer, ABIM Recertification
Examination for Nephrology
1996
American Society of Nephrology, Faculty on (ASN Computer Course
for Nephrologists
1996
National Institute of Health, The HEMO Study, Subcommittee on
Clinical Management Committee
1996
Chief, Division of Nephrology, Lankenau Hospital
1996
Clinical Professor of Medicine - Jefferson Medical College
1994
National Institute of Health Steering Committee: The HEMO Study,
Subcommittee on Publications and Ancillary Studies.
1994
Medical Advisory Group: Quantitative Medical Systems, San
Francisco, CA
1994
Invited Panelist: Consensus in the Optimal Management of Renal
Osteodystrophy: Issues in Reducing Morbidity. Chicago, IL, July
30-31, Proceedings presented at American Society of Nephrology.
1994
Invited Contributor of Questions for American Board of Internal
Medicine and Nephrology Subspecialty Recertification Exam
1993-1996Editorial Review Board, Transactions, American Society
of Artificial Internal Organs
1993-1998Medical Advisory Board, National Kidney Foundation,
Delaware Valley, Secretary/Treasurer
1993-1995Chairman, Education Committee, Lankenau Hospital
1993-1995Program Planning Committee, American Society of
Artificial Internal Organs, Nephrology/Dialysis, April 24,
1993.
1991-present Consultant, Bryn Mawr Hospital, Bryn Mawr, PA
1990
Associate, Department of Medicine, Division of Internal
Medicine
1990-1995Director, Lankenau Hospital Medical Residency Program
(6/1990) (42 residents)
1990
Vice-President, Lankenau Physicians' Association.
1990
Clinical Associate Professor of Medicine, Jefferson Medical
College, Philadelphia, PA (July 1, 1990)
1990-presentMedical Advisory Board, Lankenau Research Center
1989-2007Member, Institutional Review Board, Lankenau Medical
Research Center Lankenau Hospital, Wynnewood, PA
1989
Associate, Division of Nephrology and Department of Medicine
Lankenau Hospital, Wynnewood
1989
Consultant, Valley Forge Dialysis Center, Phoenixville, PA.
1989
Board of Directors, Lankenau Physicians Association, Lankenau
Hospital, Philadelphia, PA.
1986-2000Medical Director, Haverford Dialysis Unit, Wynnewood,
PA.
1986
Clinical Assistant Professor of Medicine, Thomas Jefferson
University Medical College,
Philadelphia, PA.
1983-1990Director, Outpatient Nephrology/Hypertension Clinic,
Lankenau Hospital, Philadelphia, PA
1983
Assistant in Division of Nephrology and Department of Internal
Medicine, Lankenau Hospital, Philadelphia, PA.
1983
Clinical Instructor, Thomas Jefferson University Medical
College, Philadelphia, PA.
1983
Consultant, Montgomery Hospital, and Montgomery Dialysis Unit,
Norristown, PA.
1983
Consultant, Main Line Dialysis Services and Haverford Dialysis
Unit, Philadelphia, PA
TEACHING RESPONSIBILITIES
Daily/weekly teaching and lectures to Nephrology fellows and LMC
House staff and students
Monthly Lecture for Jefferson Medical Students
Weekly teaching rounds in the Intensive Care Unit at Lankenau
Hospital
Surgical Grand Rounds
Didactic Lectures to House staff and Attending Staff
Daily teaching rounds with House staff
Medical Grand Rounds
Outpatient Nephrology/ Hypertension Clinic at Lankenau
Hospital
Introduction to Clinical Medicine, Thomas Jefferson University
Medical College
Morning Report with Senior Medical Residents
Bedside Teaching Rounds
Professionalism Lecture Series (ABIM)
Overseer of House staff research projects
Junior Medical Student Lectures
COMMITTEES
ACGME Residency Review Committee- Internal Medicine * (American
Society of Nephrology National Representative on Committee)
Co-Chair, Clinical Operations Committee
Co-chair, Length of Stay CommitteeChair, Quality Committee,
LMC*
Chair, Safety Committee, LMC*
Chair, Mortality Committee, LMC*
Chair, Utilization Review Committee, LMC*
Chair, Lankenau Hospital Nutrition Support Committee*
Co-Chair, Transitions of Care Committee LMC*
Co-Executive Sponsor, Acute Care Integration for CMS Bundle
MLH*
Senior Operations Team, LMC*
Business Development Committee, LMC*
Physician Steering Committee, LMC*
Physician Development Committee*
Board of Directors LIMR Foundation*
Lankenau Hospital Research and Education Committee*
Executive Sponsor Bioethics Committee, MLH*
Executive Sponsor, Root Cause Analysis LMC*
Utilization Review, LMC*
Risk Management Committee, LMC*
Graduate Medical Education Committee*
Residency Review Committee LMC*
Life Sciences and Management Board of Directors, University of
Pennsylvania*
Ex-Officio Lankenau Hospital Foundation Board of Trustees*
Ex-Officio Member of MLH Medical Executive Committee*
Ex-Officio Member Peer Review Committee LMC and PROC (MLH)*
Ex-Officio Member LMC Medical Operations Committee (MOC)*
Institutional Review Board (Research Review Committee), Lankenau
Hospital,
(Member 16 years, Vice-Chairman 10 years)
Chairman, Residents Clinical Competency Review Committee
Co-Chair, Jefferson Health System Clinical Programs Integration
Working Group
Annenberg Steering Committee
Annenberg Simulation Development Committee
MLH Board of Governors (Ex-Oficio)
MLH Joint Conference Committee
Search Committee Co-Chairman for Vice President of Patient
Services
Family Practice Chairman Search Committee for Main Line
Health
Ad Hoc Committee for Development of Main Line Health Vascular
Medicine
Nominating Committee, Lankenau Hospital
Board of Directors, Lankenau Physician Association
Chairman, Development and Entertainment, Lankenau Hospital
Morbidity and Mortality, Lankenau Hospital
Subspecialty Subcommittee on Clinical Competence
Main Line Health Medical Education Committee
Lankenau Hospital Department of Internal Medicine Education
Subcommittee.
Chairman, Lankenau Hospital Education Committee
Main Line Health Corporate Hospital Rating Project Focus
Group
Documentation Process Improvement Team
Vice-Chairman, Main Line Health Medical Executive Committee
Chairman, Main Line Health Search Committee for Department of
Emergency Medicine
Vice-Chairman, Main Line Institutional Review Board
Main Line Health Cardiac Reconfiguration Advisory Council
Medical Subspecialists Subcommittee
Co-Chairman, Lankenau Development and Physician Giving
Campaign
Department Chief of General Surgery Search Committee
Foundation Board Investment Committee
Sharpe Foundation Medical Research Committee
Lower Merion Educational Foundation Board
ABSTRACTS AND PRESENTATIONS
86.Value of Inpatient PTH Levels in Hospitalized Chronic ESRD
Patients. April 22 2014. National Kidney Foundation Scientific
Meeting Sampath Thiruveedi and Robert L. Benz, MD
85.IgA Vasculitis (HSP nephritis) Associated with Cystic
fibrosis – case report Sampath Thiruveedi and Robert L. Benz, MD
Sampath Thiruveedi, Robert L Benz. Lankenau Medical Center,
Wynnewood, PA
84.Handelman GJ, Liu Y, Levin NW, Kotanko P, Benz RL, Logan A,
Avila JA,
Prasad, D, Weisberg LS, Sirover WD. Relationship of Ascorbic
Acid Levels to
Vitamin Supplementation in a Prevalent Hemodialysis Population.
J Am Soc
Nephrol 23: 2012, p. 763. Poster presententation, American
Society of Nephrology,
Atlanta, GA, November 3, 2012
83.R.L. Benz, A.A. Siddiqui, W.D. Sirover. Beneficial Effects of
Daily Oral Vitamin C
Therapy on Hematologic Parameters and Erythropoeitin Dose in
Hemodialysis
Patients. Abstract presented at American Society of Nephrology
37th Annual
Meeting and Scientific Exposition, St. Louis, Mo. October
2004.
82. Sirover WD, Salzman, B, McFadden CB. Principles of Fluid and
Electrolyte Balance and Renal Disorders in the Older Patient.
Reichel’s Care of the Elderly, 7th Edition (in press)
81. Sirover WD, Liu Y, Logan A, Hunter K, Benz RL, MD, Prasad D,
Avila J,
Venkatchalam T, Weisberg LS, MD, Handelman GJ. Plasma Ascorbic
Acid
Concentrations in Prevalent Patients with End Stage Renal
Disease on
Hemodialysis. Journal of Renal Nutrition (in press)
80.Benz, R. “Reduction in Cardiac Events At The Chronic
Hemodialysis Unit After the Implementation of Ultrafiltration
Restriction and Other Risk Factors Modification.”
Poster presentation at National Kidney Foundation Conference,
April 3-4, 2013, Orlando, Florida
80. Benz, R. Pre-Eclampsia Associated with Severe
Hyponatremia.”
Poster presentation at National Kidney Foundation Conference,
April 3-4, 2013, Orlando, Florida.
79.Benz R, Htike N, Siddiqui A, Teehan G. “Does obtaining
urinary diagnostic studies prior to renal consultation affect
outcomes in acute kidney injury patients?” Accepted for
presentation at the National Kidney Foundation, 2012, Spring
Clinical Meetings to be held May 9-13, 2012, at Gaylord National in
National Harbor, MD
78. Htike N, Siddiqui A, Teehan G, Benz R. Preconsultation
Evaluation and Outcome in Acute Kidney
Injury Patients. The American Society of Nephrology. May
2011.
77.Benz R, Drummond D. A Physician Driven Approach to Reducing
Expenses. Premier Breakthrough Conference. Nashville, TN June 15,
2011.
76.Benz R, Mathews R, Pressman M, Chernick M, Keshgegian A,
Mushfiq O, “Elevated plasma brain natriuretic peptide (BNP) levels
in hemodialysis (HD) patients and its lack of correlation with
volume status.” National Kidney Foundation Annual Scientific
Meeting Poster Presentation, Las Vegas, NV, April 2011.
75.Finnigan N, Chernick M, Benz R, “N-Acetylcysteine (NAC) May
Improve Erythropoietin Resistant Anemia (ERA) in Hemodialysis
Patients.” American Society of Nephrology: Denver Meetings Poster
presentation 11/2010.
74.Benz R, Mathews R, Pressman M, Chernick M, Keshgegian A,
Mushfiq O, “Prevalence of elevated plasma brain natriuretic peptide
levels in hemodialysis patients and its correlation with
sleep-disordered breathing”. American Society of Nephrology: Denver
Meetings Poster presentation 11/2010.
73.Finnigan N, Benz R, Siddiqui A, Moe K, Umruddin Z: C-Reactive
Protein (CRP) Predicts Response to Nutritional Enhancement in
Hemodialysis Patients with Low Serum Albumin. American Journal of
Kidney Diseases, April 2010 Vol 55 Issue 4, Page B43.
72.Finnigan N, Benz R, Siddiqui A, Moe K, Umruddin Z: C-Reactive
Protein (CRP) Predicts Response to Nutritional Enhancement in
Hemodialysis Patients with Low Serum Albumin. Presented at National
Kidney Foundation Scientific Meeting, April 2010, Orlando FL.
71.Benz R, Mathews R, Pressman M, Chernick M, Keskgegian A,
Mushfiq O: Elevated plasma brain natriuretic peptide (BNP) levels
in Hemodialysis (HD) Patients with Sleep Apnea (SA). Presented at
the American Society of Nephrology Scientific Meeting 2010.
70.Benz R, Mathews R, Pressman M, Chernick M, Keskgegian A,
Mushfiq O: Elevated plasma brain natriuretic peptide (BNP) levels
in Hemodialysis (HD) Patients with Sleep Apnea (SA). National
Kidney Foundation Scientific Meeting, April 2010.
69.Sirover WD, Kelley K, Weisberg L, Benz RL, Handelman G:
Indicators of Iron Status in Relation to Plasma Vitamin C in
Hemo-Dialysis Patients. JASN Vol 19, November 2008 Abstracts Issue
p. 919.
68.Moe K, Htike N, Robbins P, Siddiqui A, Benz R: Efficacy and
Outcomes of Cincalcet Use for Primary Hyperparathyroidism Managed
by Nephrologists. JASN Vol 19, November 2008 Abstracts Issue
p.915.
67.Sharma M, Moe K, Benz R: Increased Morbidity with Coronary
Angiography when Accompanied by Renal Angiography. American Society
of Nephrology, ASN Renal Week, San Francisco CA, April 2007.
66.Wu X, Benz R, Pressman M: Increase of Periodic Limb Movements
in Sleep During Successful Treatment of Sleep Apnea in Chronic
Kidney Disease Patients. National Kidney Foundation Spring Clinical
National Meeting, Orlando FL, April 11, 2007. (American Journal of
Kidney Disease, April 2007)
65.Spinowitz B, Germain M, Benz R, Wolfson M, McGowan T for the
Epoetin Alfa Extended Dosing Study Group: Extended Doses Regimens
for Initiation of Epoetin Alfa for Treatment of Anemia of Chronic
Kidney Disease. National Kidney Foundation Spring Clinical National
Meeting, Orlando FL, April 11, 2007. (American Journal of Kidney
Disease, April 2007)
64.Coyne D, Zeig R, Benz R, Berns J, et al. A Randomized,
Double-Blind Study Comparing Darbepoetin Alfa and Recombinant Human
Erythropoietin (rHuEPO) in the Treatment of Anemia in
African-American (AA) Subjects with Chronic Kidney Disease (CKD)
Receiving Hemodialysis (HD). American Society of Nephrology 39th
Annual Meeting, San Diego CA, November 14-19 2006.
63.Benz R, Schmidt R, Kelly K, Wolfson M. Impact of Epoetin Alfa
Once Every Two Weeks on Quality of Life in Anemic Subjects with
Chronic Kidney Disease. American Society of Nephrology 39th Annual
Meeting, San Diego CA, November 14-19 2006.
62.Wu X, Benz R, Pressman M. Increase in Periodic Limb Movements
in Sleep during Treatment of Sleep Apnea with Continuous Positive
Airway Pressure (CPAP) in the Advanced Chronic Kidney Disease
Population. American Society of Nephrology 39th Annual Meeting, San
Diego CA, November 14-19 2006.
61.Benz R, Schmidt R, Kelly K, Wolfson M. Epoetin Alfa Once
Every Two Weeks is Effective for Initiation of Treatment of Anemia
of Chronic Kidney Disease. American Society of Nephrology 39th
Annual Meeting, San Diego CA, November 14-19 2006.
60.Sirover WD, Benz RL, Siddiqui AA. Oral Ascorbic Acid Therapy
Can Reduce Hyperferritinemia and Erthyropoietin (EPO) Dose in
Anemic Hemodialysis Patients. American Society of Nephrology 38th
Annual Meeting, Philadelphia PA, November 8-13, 2005.
59.Jayaraman VP, Benz RL, Chemiti GK. Reduction of
Radiocontrast-Induced Acute Renal Failure (RCARF) Following
Cornoary Angiography (CA) by Introduction of N-Acetylcysteine (NAC)
(Mucomyst) Protocol in CKD Patients. American Society of Nephrology
38th Annual Meeting, Philadelphia PA, November 8-13, 2005.
58.Benz RL, Schmidt R, Bhaduri S, Kelly K. Use of Epoetin alfa
Once Every Two Weeks for the Initiation of Treatment of Anemia of
Chronic Kidney Disease. American Society of Nephrology 38th Annual
Meeting, Philadelphia PA, November 8-13, 2005.
57.Press MH, Benz RL. Higher Target Urea Reduction Ratio (URR)
May Optimize Achievement of K/DOQI Goal. American Society of
Nephrology 38th Annual Meeting, Philadelphia PA, November 8-13,
2005.
56.Benz RL, Siddiqui A, Sirover W. Beneficial Effects of Daily
Oral Vitamin C Therapy on Hematologic Parameters and Erythropoietin
Dose in Hemodialysis Patients. American Society of Nephrology 37th
Annual Meeting, St. Louis Missouri, October 29 - November 1,
2004.
55.Unruh M, Yan G, Radeva M, Hays R, Benz RL, et al. Bias in
Assessment of Health-Related Quality of Life in a Hemodialysis
Population: A Comparison of Self-Administered and
Interviewer-Administered Surveys in the HEMO Study. J Am Soc
Nephrol 14:132-2141, 2003.
54.Benz RL, Pressman RP, Brown J. Does membrane flux or dialysis
eKt/V does effect ESRD related sleep disorders in hemodialysis
patients? An ancillary study of the HEMO Trial. American Society of
Nephrology 35th Annual Meeting, Philadelphia PA, October
30-November 4, 2002.
53.Meyer K, Benz RL, for the HEMO Study Group: Quality of Life
(QOL) Outcomes in the HEMO Study. Presented at the ASN 35th Annual
Meeting, October 30 - November 4, 2002, Philadelphia, PA. J Am Soc
Nephrol 13: 2002 page 421A-422A
52.Chemiti G, Benz RL, Pressman MR: How Do Body Mass Index (BMI)
and Serum Albumin Correlate with End Stage Renal Disease (ESRD) -
Related Sleep Apnea in Hemodialysis (HD) Patients? Presented at the
ASN 35th Annual Meeting, October 30 - November 4, 2002,
Philadelphia, PA. J Am Soc Nephrol 13: 2002 page 585A
51.Verma A, Benz RL: Prevalence of Sleep Disorder Symptoms in
Patients with Chronic Renal Insufficiency. Presented at the ASN
35th Annual Meeting, October 30 - November 4, 2002, Philadelphia,
PA. J Am Soc Nephrol 13: 2002 page 256A-257A
50.Benz RL, Pressman M, Chemiti G.: Nutritional Profiles
Correlate with Periodic Limb Movements in Sleep (PLMS) in
Hemodialysis Patients (HD Pts). Presented at the ASN 35th Annual
Meeting, October 30 - November 4, 2002, Philadelphia, PA. J Am Soc
Nephrol 13: 2002 page 585A
49.Benz RL, Pressman M, Brown J: Does Membrane Flux (F) or
Dialysis eKT/V Dose (K) Affect ESRD-Related Sleep Disorders in
Hemodialysis (HD) Patients (Pts)? An Ancillary Study of the HEMO
Trial. Presented at the ASN 35th Annual Meeting, October 30 -
November 4, 2002, Philadelphia, PA. J Am Soc Nephrol 13: 2002 page
20A
48.Chemiti GK, Benz RL, Pressman MR: Lower Body Mass Index and
Albumin Correlate with Increased Frequency of Central Sleep Apnea
in Hemodialysis Patients. Presented at American Society of
Artificial Internal Organs, New York, NY, April 2002.
47.George D, Benz RL, Chemiti GK: Hospitalizations and R-HuEPO
Hyporesponsiveness in (HD) Hemodialysis Patients. Presented at
American Society of Artificial Internal Organs, New York, NY, April
2002.
46.Benz RL, Pressman MR, Chemiti GK: Poor Nutritional Profiles
in Hemodialysis Patients Correlate with Increased Periodic Limb
Movements in Sleep Index. Presented at American Society of
Artificial Internal Organs, New York, NY, April 2002.
45.Meyer K, Paranandi L, Hays R, Benz RL, Athienites N, Kusek J,
Levey A and the HEMO Study Group. Quality of Life in the HEMO
Study: An Interim Report. JASN, Vol 8, 204A, Sept 1997. Presented
at the ASN 30th Annual Meeting, November 2-5, 1997, San Antonio,
TX.
44.Rocco M, Benz RL, Burkart J, Cheung A, Heyka R, and Irving S,
Wright C. and the HEMO Study Group. Baseline Blood Pressure in HEMO
Study Participants: An Interim Report. JASN, Vol 8, 250A, Sept
1997, Presented at the ASN 30th Annual Meeting, November 2-5, 1997,
San Antonio, TX.
43.Benz RL, Pressman MR, Hovick ET, Peterson DD: Anemia of
Chronic Renal Failure (Ancrf), Sleep Disorders and Daytime
Alertness: Benefits of Normalizing Hematocrit (The Sleepo Trial),
American Society for Artificial Internal Organs, Atlanta, GA, May
1, 1997.
42.Benz RL, Pressman MR, Hovick ET, Peterson DD: Relationship
between anemia of chronic renal failure and sleep, sleep disorders
and daytime alertness: benefits of normalizing hematocrit (the
SLEEPO Trial). 1996 Annual Meeting of the American Society of
Nephrology. Minisymposia Session on Quality of Life and Health
Status in Chronic Renal Disease. New Orleans, LA November 3, 1996.
Published in: JASN, Sept 1996, Vol 6, #9, p1473.
41.Benz RL: Predictors of Mortality in ESRD Patients with Sleep
Disorders. 1996 Annual Meeting of the American Society of
Nephrology. Session on Morbidity and Mortality of ESRD Patients.
Poster presentation. New Orleans, LA November 5, 1996. *Awarded ASN
Blue Ribbon
Published in: JASN, Sept 1996, Vol 7, #9, p1439.
40.Samimi F, Thornton EA, .... Benz RL, et al: Comparative Study
of Temporary Hemodialysis Catheter. Tucson, AZ, Presented May
1996.
Benz RL: Epoetin alfa Therapy in Hospitalized Patients, New
Directions in Anemia, A Profile of the Anemic Dialysis Patient,
1995, Vol. 6, No. 1.
39.Benz RL, Pressman MR, Peterson DD: Utility of Periodic Leg
Movements of Sleep (Plms) Index (I) to Predict ESRD Mortality. 6th
Asian Pacific Congress of Nephrology, Hong Kong, Presented December
5-9, 1995.
38.Simenhoff ML, Dunn SR, Fitzpatrick MF, Emery S, Gaughan W,
Wrigley M, Benz RL, Bergen C, Sandine W, Ayres J: Comparison of
Short (ST) and Long-Term (LT) Therapy Using Freeze-Dried
L.acidophilus (LBA) in Dialysis Patients with Small Bowel Bacterial
Overgrowth (SBBO). International Society of Nephrology, Madrid,
Spain. July 1995.
37.Pressman MR, Benz RL, Peterson DD: High incidence of sleep
disorders in end-stage renal disease patients. Oral presentations
at 9th Annual Meeting of Association of Professional Sleep Society,
Nashville, Tenn, June 4, 1995. Abs. Sleep Research 25, 321.
36.Pressman MR, Benz RL, Peterson DD: Periodic leg movements in
sleep index (PLMSI) predicts mortality in end-stage renal disease
patients. Oral presentation at 9th Annual Meeting of Association of
Professional Sleep Society, Nashville, Tenn, June 4, 1995.
35.Benz RL, Pressman MR, Peterson DD: Utility of Periodic Leg
Movements of Sleep (PLSM) Index (I) to Predict ESRD Mortality.
American Society of Artificial Internal Organs, Chicago, IL, May
1995.
34.Benz RL, Pressman MR, Peterson DD: Periodic Leg Movements of
Sleep Index (PLMSI): A Sensitive Predictor of Mortality in Dialysis
Patients. American Society of Nephrology, Orlando, FL, October 28,
1994. Presented by RL Benz. JASN Vol 5, #3, Sept 1994, pg 433
(Abs.)
33.Revicki D, Brown R, Sarokhan B, Teehan BT, Rudnick M, Benz
RL: Functional Status and Well-Being in Pre-Dialysis Chronic Renal
Disease Patients Treated with Recombinant Human Erythropoietin.
Drug Information Association Second Annual Symposium of Contributed
Papers on Quality of Life Evaluation. Charleston, SC., October 17,
1994 Presented by RL Benz.
32.Benz RL, Hovick ET: Post-Thrombectomy Same-Day Hemodialysis
Influence Graft Patency." Presented at Annual Meeting of American
Society of Nephrology, Boston, MA, November 16, 1993.
31.Pressman MR, Benz RL, Smith BS, Figueroa WG, Greenspon LW,
Meyer TJ, Peterson DD: Prevalence of Repetitive Central Sleep
Apneas of End-Stage Renal Failure is Significantly Less in REM
Sleep Compared to NREM Sleep. Assoc. of Professional Sleep Soc,
Boston, MA, June 7, 1994.
30.Benz RL, Pressman MR, Schleifer CR, Peterson DD: (Sleep
Disorders of Chronic Renal Failure Patients: Successful
Intervention with Nasal Continuous Positive Airway Pressure
Therapy.( Presented at International Congress of Nephrology,
Jerusalem, Israel, June 1993.
29.Benz RL, Teehan BP, Rudnick M, Roth D, et al: Renal Function
and Quality of Life Studies in Anemic Pre-Dialysis Chronic Renal
Failure Patients Receiving Recombinant Human Erythropoietin:
Results of a Multi-Center Trial. Presented at International
Congress of Nephrology, Jerusalem, Israel, June 1993.
28.Benz RL, Pressman MR, Schleifer CR, Peterson DD: (Successful
Nasal Continuous Positive Airway Pressure Therapy in Sleep
Disorders of Chronic Renal Failure Patients.( Presented at the 39th
Annual Meeting of American Society for Artificial Organs, New
Orleans, LA, May 1, 1993.
27.Benz RL, Hovick ET: (Does Post-Thrombectomy Same-Day
Hemodialysis Influence Graft Reclotting Rates?( Presented at the
39th Annual Meeting of American Society for Artificial Organs, New
Orleans LA, April 30, 1993.
26.Benz RL, Teehan BP, Buckalew V, Hatch F, Roth D, Rudnick M,
Schuman G, Shadur C, Sloand J, Smith R, Steinman T, Williams W and
Abels R: (Health-related Quality of Life Issues (HRQOL) Associated
with Recombinant Human Erythropoietin Therapy (rHuEPOTx) in
Predialysis Chronic Renal Failure (CRF) Patients.( Presented at the
Joint Session of national Kidney Foundation and American Society of
Nephrology, Baltimore, MD, November 17, 1992. (Abs - National
Kidney Foundation Program, November 1992, pg A2).
25.Benz RL, Pressman MR, Schleifer CR, Peterson DD: (Sleep
Disorder Profiles in Chronic Renal Failure (CFR) Patients:
Successful Intervention with Nasal Continuous Positive Airway
Pressure (NCPAP).( Presented at Joint Session of National Kidney
Foundation and American Society of Nephrology, Baltimore, MD,
November 17, 1992. (Abs - National Kidney Foundation Program,
November 1992, pg A1.)
24.Caruso RF, Benz RL: (Sclerosing Cholangitis, Adrenal
Insufficiency and Functional Hyposplenism: Coincidence or
Syndrome?( Subspecialty session of the Annual Eastern and Western
PA Regional American College of Physicians, October 3, 1992.
23.Bralow SA, Benz RL: (Renovascular Hypertension Following
Incidental Surgical Occlusion of an Accessory Renal Artery
Subspecialty session of the Annual Eastern and Western PA Regional
American College of Physicians, October 3, 1992.
22.Hovick ET, Benz RL and Abramson J: (Watery Diarrhea,
Hypokalemia Syndrome in a Chronic Dialysis Patient.( Subspecialty
session of the Annual Eastern and Western PA Regional American
College of Physicians, October 2, 1992.
21.Roth D, Benz RL, Buckalew V, Freedman B, Hatch F, Rudnick M,
Schulman G, Shadur C, Sloand J, Smith R, Steinman T, Teehan BP,
Williams W and Abels R: (Renal Function in Predialysis Patients
receiving Recombinant Human Erythropoietin (r-HuEPO) Therapy for
the Anemia of Chronic Renal Insufficiency (CRI), Interim Results of
a Multi-Center Trial.( American Society of Nephrology, Baltimore,
MD, November 17, 1992 (Abs - J Am Soc Neph, Vol 3, Num 3, p 431,
September 92).
20.Benz RL, Teehan BP, Bergen C: (Administered vs Prescribed
Intravenous Calcitriol (IVC) Therapy in Hemodialysis Patients:
Questionable Adequacy of Delivered Care.( Presented at the American
Society of Nephrology, Baltimore, MD, November 15, 1992. (Abs J Am
Soc Neph, Vol 3, Num 3, pg 354, September 92.)
19.Pressman MR, Benz RL, Peterson DD and Schleifer CR:
(Successful NCPAP Treatment of Central and Mixed Sleep Apnea in
End-Stage Renal Disease.( American Association of Sleep
Specialists, Phoenix, AZ, June 1992
18.Benz RL, Teehan BP: (Factors Limiting Intravenous Calcitriol
(IVC) Dosing in Hemodialysis (HD) Patients.( Presented at ASAIO
38th Annual Meeting, Nashville, TN, May 7-9, 1992.
17.Benz RL: (Factors Determining Intravenous Vitamin D3 (ID)
Dosing in Hemodialysis (HD) Patients.( Journal of the American
Society of Nephrology, Vol 2, Number 3, p 315, September 1991.
16.Benz RL: (Evaluation of Underachieving Residents Utilizing a
Subspecialty Subcommittee on Clinical Competence.( Presented at the
Association of Program Directors in Internal Medicine, April 9,
1991, New Orleans, LA.
15.Sigler MH, Snyder S, Teehan BP, Benz RL: (Amino acid during
continuous arteriovenous hemodialysis (CAVHD) in patients with
acute renal failure (ARF) receiving total parenteral nutrition.(
Presented at the International Conference on Continuous
Hemofiltration, September 20-21, 1990, Baden, Austria.
Intensivbehandlung, 1990.
14.Benz RL, Teehan BP, Gilgore GS, Sigler MH, Schleifer CR: (The
Effects of the Osmotic Diuretic Mannitol on Renal Vein Renin
Profiles,( 11th International Congress of Nephrology in Tokyo,
Japan, July, 1990.
13.Benz RL: (Current Clinical Concepts: Evolution of r-HuEPO in
the Anemia of Chronic Renal Failure( at the 24th Annual Meeting of
the American Society of Hospital Pharmacists, Atlanta, Georgia,
December 6, 1989.
12.Benz RL, Teehan BP, Gilgore GS, Sigler MH, Schleifer CR:
Suppression and Masking of Renal Vein Renin Profiles Induced by
Mannitol Prophylaxis. Presented at the Fourth Scientific Meeting of
the American Society of Hypertension, May 12, 1989, New York, NY.
Am J Hypertension, Vol 2, Number 5, Part 2, May 1989, p 10A.
11.Benz RL, Teehan BP, Sigler MH, Gilgore GS, Schleifer CR:
Effects of the Osmotic Diuretic Mannitol on Renal Vein Renin
Profiles. International Conference on Diuretics, Mexico, April
1989.
10.Schleifer CR, Teehan BP, Sigler MH, Gilgore GS, Benz RL: The
Effect of Total Urea Nitrogen (N) Clearance (KT) and Protein (P)
Nutrition on Morbidity and Mortality in Continuous Ambulatory
Peritoneal Dialysis (CAPD). Pennsylvania Society of Nephrology
Annual Meeting in conjunction with the Regional Meetings of the
American College of Physicians and the Pennsylvania Society of
Internal Medicine. November 1988.
9.Sigler MH, Snyder S, Teehan BP, Benz RL: Amino Acid Removal
During Continuous Arteriovenous Hemodialysis (CAVHD) in Patients
with Acute Renal Failure Receiving Total Parenteral Nutrition.
Presented by RL Benz at the 5th International Congress on Nutrition
and Metabolism in Renal Disease, Strasbourg, France, September
1988.
8.Teehan BP, Schleifer CR, Benz RL, et al: The Effect of Total
Urea Nitrogen Clearance and Protein Nutrition on Morbidity and
Mortality in Continuous Ambulatory Peritoneal Dialysis. Poster
Presentation by Dr. RL Benz at the 5th International Congress of
Metabolism and Nutrition in Renal Disease, Strasbourg, France.
September 1988.
7.Benz, RL: Does Erythropoietin Therapy Alter the Rate of
Progression of Renal Failure? Presented at the 5th International
Congress of Metabolism and Nutrition in Renal Disease, Strasbourg,
France. September 1988.
6.Benz, RL: Impact of Erythropoietin in the Pre-End Stage Renal
Failure Patients. Presented at the 4th Annual Advanced Dialysis
Technical Symposium, Chicago, Illinois. June 1988.
5.Benz RL, Schleifer CR, Teehan BP, Gilgore GS, Sigler MH:
Successful Treatment of Post-Parathyroidectomy Hypocalcemia with
Continuous Ambulatory Intraperitoneal Calcium (CAIC) Therapy.
Presented at the 8th National Conference on CAPD, Kansas City,
Missouri, February 1988. Published in Peritoneal Dialysis
International, Vol 8 #1, p 66, 1988.
4.Schleifer CR, Benz RL, Teehan BP: Serum Acid Phosphatase and
Parathyroid Hormone in Continuous Ambulatory Peritoneal Dialysis
and Hemodialysis. 1987 Annual Meeting of the American Society of
Nephrology, Washington, D.C.
3.Benz RL: Carpal Tunnel Syndrome in CAPD: Comparison with a
Hemodialysis Population. Presented at the Joint Session of the
National Kidney Foundation and the American Society of Nephrology,
1986.
2.Benz RL, Schleifer CR, Raimondo J, Read K, Ziemek H: Rifampin
Induced Sunset Dialysate.
The American Society of Nephrology, p. 79A, 1984. Kidney
International, Vol. 27, p. 177, 1985.
1. Benz RL: Spontaneous Platelet Aggregation in Metastatic
Adenocarcinoma. Presented at the Eastern Pennsylvania American
College of Physicians, 1981. Nominated for Governor's Award.
PUBLICATIONS- Peer Reviewed
30. Benz R, Finnegan N, Elfinbein. IgM Nephropathy in a Patient
with Systemic Lupus"
The American Journal of the Medical Sciences, Dec 2011.
29. Benz R, Pressman M, Wu X. Periodic Limb Movements in Sleep
Revealed by Treatment of Sleep Apnea with Continuous Positive
Airway Pressure in the Advanced Chronic Kidney Disease Population,
Clinical Nephrology. Dec 2011, Clinical Nephrology, Vo. 76 – No.
6/2011 (470-474)
28. Teehan G, Benz RL. An Update on the Controversies in Anemia
Management in Chronic Kidney Disease: Lessons Learned and Lost.
Anemia, (2011), Article ID 623673.
27.Sirover WD, Siddiqui AA, Benz RL. Beneficial Hematologic
Effects of Daily Oral Ascorbic Acid Therapy in ESRD Patients with
Anemia and Abnormal Iron Homeostasis: A Preliminary Study. Renal
Failure, Volume 30 Issue 9, 884, October 2008.
26.Spinowitz B, Germain M, Benz R, Wolfson M, McGowan T, Tang
KL, Kamin M; Epoetin Alfa Extended Dosing Study Group. A Randomized
Study of Extended Dosing Regimens for Initiation of Epoetin Alfa
Treatment for Anemia of Chronic Kidney Disease. Clin J Am Soc
Nephrol. 2008 July: 3(4): 1015-1021, Epub 2008 Apr 9.
25.Sharma M, Gilbert B, Benz R, Santoro J: Disseminated Nocardia
Otitidiscaviarum Infection in a Woman with Sickle Cell Anemia and
End-Stage Renal Disease: The American Journal of the Medical
Sciences, Volume 333 Number 6: pages 372-375, June 2007.
24.Benz R, Schmidt R, Kelly K, Wolfson M. Epoetin Alfa Once
Every 2 Weeks is Effective for Initiation for Treatment of Chronic
Kidney Disease. Clinical Journal of the American Society of
Nephrology. Volume 2 Number 2: 215-221, 2007.
23.MH Press, RL Benz. Quantifying the Role of Factors that Limit
Attainment of K/DOQI Urea Reduction Ratio Dialytic Goal. Clinical
Nephrology, Volume 66-2/2006: 98-102, August 2006.
22.Unruh M, Miskulin D, Yan G, Hays R, Benz R, Kusek J, Meyer K
and the Hemo-Study Group. Racial Differences in Health-Related
Quality of Life Among Hemodialysis Patients: KI Volume 65 Number 4:
1482-1491, April 2004.
21.Unruh M, Yan G, Radeva M, Hays R, Benz R, Athienites N, Kusek
J, Levey, A, Meyer K, HEMO Study Group - Bias in Assessment of
Health-Related Quality of Line in a Hemodialysis Population: A
Comparison of Self-Administered and Interviewer-Administered
Surveys in the HEMO Study: J Am Soc Nephrol 14:2132-2141, 2003.
20.Quarles DL, Sherrard DJ, et al - Investigator
Acknowledgement: The Calcimimetic AMG 073 as a Potential Treatment
for Secondary Hyperparathyroidism of End-Stage Renal Disease: J Am
Soc Nephrol 14: 575-583, 2003.
19.Rocco M, Benz RL, Burkart J, Cheung A, Heyka R, and Irving S,
Wright C. and the HEMO Study Group. Baseline Blood Pressure in HEMO
Study Participants: An Interim Report. Accepted for Publication in
JASN, 2001.
18.Benz RL, Pressman MR, Hovick EH, Peterson DD: Potential Novel
Predictors of Mortality in End-Stage Renal Disease Patients With
Sleep Disorders. Am J Kid Dis Vol 35, No 6 (June) 2000: pp
1052-1060. (See also editorial pp 1221-1223)
17.Benz RL, Pressman MR, Hovick EH, Peterson DD: A Preliminary
Study of the Effects of Correction of Anemia with Recombinant Human
Erythropoietin Therapy on Sleep, Sleep Disorders and Daytime
Sleepiness in Hemodialysis Patients (The SLEEPO Study). Am J Kid
Dis, Vol 34, Issue 6 (December), 1999:pp 1089-1095.
16.**Norcini JJ, Blank LL, Arnold GK, Kimball HR: The Mini-CEX
(Clinical Evaluation Exercise): A Preliminary Investigation. Ann
Intern Med. 1995; 123:795-799. (Acknowledged participant)
15.Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick
MR, Benz RL: Health-Related Quality of Life Associated with
Recombinant Human Erythropoietin Therapy for Predialysis Chronic
Renal Disease Patients. Am J Kid Dis, Vol 25, No. 4 (April),
1995:pp 548-554.
14.Roth D, Smith RD, Schulman G, Benz RL, Teehan BP et al:
Effects of r-HuEPO on Renal Function in Chronic Renal Failure
Predialysis Patients, Am J Kid Dis, Vol 24, No. 5 November, 1994:pp
777-784.
13.Benz RL: Monitoring Adequacy of Therapy of Secondary
Hyperparathyroidism in Hemodialysis Patients: Utility of the
Intravenous Calcitriol Index. Nephrology Exchange, Nov. 1993, Vol
3; #1.
Pressman MR, Benz RL, Schleifer CR, Peterson DD: Sleep
Disordered Breathing in End Stage Renal Disease: Acute Beneficial
Effects of Treatment with Nasal Continuous Positive Airway Pressure
(NCPAP), Kidney International, Vol 43, #5, 1134-1139, 1993.
12.Ifedoria O, Benz RL: Renal Papillary Necrosis in a
Hemodialysis Patient, Clinical Nephrology, Vol. 39, #5, 279-281,
May, 1993.
11.Benz RL, Teehan BP, Sigler MH, Gilgore GS and Schleifer CR:
Suppression of Renal Vein Renin Profiles by Mannitol Prophylaxis:
Implications in the Evaluation of Renovascular Hypertension. Am J
Kid Dis, Vol 18 (6) 649-654, December 1991.
10.Benz RL, Teehan BP and Brown JM: Management of Anemia in
Predialysis. Contemporary Dial & Neph, Vol. 12, Number 11, pp
52-58, November 1991.
9.*Benz RL: Use of Recombinant Human Erythropoietin (r-HuEPO) in
Patients with Chronic Renal Failure (Predialysis). MONOGRAPH -
Recombinant Human Erythropoietin - Current Clinical Concepts in
Hospital Pharmacy. Communications Media for Education, Inc.
1990.
8.Teehan BP, Benz RL, Sigler MH, Brown JM: Early Intervention
with Recombinant Human Erythropoietin Therapy. Seminars in
Nephrology, Vol 10, No. 2, Suppl 1 (March), 1990: pp 28-34.
7.Benz RL, Schleifer CR, Teehan BP, Sigler MH, Gilgore GS:
Successful Treatment of Postparathyroidectomy Hypocalcemia Using
Continuous Ambulatory Intraperitoneal Calcium (CAIC) Therapy.
Peritoneal Dialysis International, Vol 9, pp 285-288, 1989.
6.Schleifer CR and Benz RL: Lactobacillus Acidophilus
Peritonitis in CAPD. Peritoneal Dialysis International, Vol 9, pp
222-223, 1989.
5.Teehan BP, Sigler MH, Brown JM, Benz RL, Gilgore GS, Schleifer
CR, Morgan CM, Gabuzda TG, Kelly JJ, Figueroa WG, Peterson DD:
Hematologic and Physiologic Studies During Correction of Anemia
with Recombinant Human Erythropoietin in Predialysis Patients.
Transplantation Proceedings, Vol XXI, No. 6, Suppl 2 (December), pp
1-5, 1989.
4.Benz RL, Teehan BP, Sigler MH, Brown JM: What Will be the
Impact of Erythropoietin on Chronic Dialysis? Seminars in Dialysis,
April-June, Vol 2, No 2, pp 75-78, 1989.
3.Benz RL, Siegfried JW, Teehan BP: Carpal Tunnel Syndrome in
Dialysis Patients: Comparison Between CAPD and Hemodialysis
Populations. Am J Kid Dis 11 (6) June, l988.
2.Schleifer CR, Ziemek H, Teehan BP, Benz RL, Sigler MH and
Gilgore GS: Migration of Peritoneal Catheters: Personal Experience
and a Survey of 72 Other Units. Perit Dial Bull, Vol 7, Number 3,
pp 189‑193, July-Sept 1987.
1.Benz RL, Schleifer CR: Hydrothorax in Continuous Ambulatory
Peritoneal Dialysis: Successful Treatment with Intrapleural
Tetracycline and a Review of the Literature. Am J Kid Dis, Vol 5,
(2) pp 136‑140, 1985.
Publications Non-Peer Reviewed
3.*Benz R, Breiterman-White R. Optimizing Care for Patients on
Hemodialysis: Managing Hyporesponse to Erythropoeisis Stimulating
Therapy: DVD and Workbook; Continuing Education Alliance Accredited
Services for Healthcare Professionals, pages 1-40, March 2007
2.Eknoyan G, et al (The HEMO Study Group) - Investigator
Acknowledgement: Effect of Dialysis Dose and Membrane Flux in
Maintenance Hemodialysis - The HEMO Study: NEJM Volume
347:2010-2019, December 19, 2002.
1. *Benz RL: Developing a Protocol for Use of Intravenous
Calcitriol: Guidelines and Caveats. OsteoDynamics, 1995, Vol. 3,
No. 2, Summer
CHAPTERS
12.Saifullah N. Kazi and Robert L. Benz “Work up of Hematuria”
Primary Care Clinics in Office Practice 41:4 Nephrology. Elsevier,
November, 2014.
11. Benz, R, “Adjuvant Therapy for Treatment of Anemia for CKV”,
Chronic Kidney Disease, In-Tech, September 2011 (In Press)
10.Benz, R, “Sleep Disorders Associated with Chronic Kidney
Disease” Accepted for publication July 2011, Chronic Kidney Disease
ISBN 979-953-307-048-2
9.Peck G, Burhan U, Benz R, “Low Urine Output” in SURGERY: A
Competency-Based Companion, editor Mann BD, Elsevier, March,
2008.
8.Benz RL, Pressman MR, Nicholls AJ: Nervous System and Sleep
Disorders. Handbook of Dialysis 4th Edition pages 700 -713, 2006.
Lippincott, Williams and Wilkins
7.Pereira BJG, Benz RL, Collins AJ, Levison SJ: The Management
of Chronic Renal Insufficiency-Related Anemia; An Expert Analysis
of Findings Presented at the 33rd Annual Meeting of the American
Society of Nephrology. Jointly Sponsored by Medical Education
Resources and Current Therapeutics, Inc., 2001.
6.Livornese LL, Slavin D, Benz RL, Ingerman MJ, Santoro J: Use
of Antibacterial Agents in Renal Failure. Infectious Disease
Clinics of North America Volume 14 #2 pgs. 371-390, June 2000. WB
Saunders
5.Benz RL, Pressman MR: Sleep Disorders in End-Stage Renal
Failure and Dialysis. Handbook of Dialysis, Third Edition, Eds.
Daugirdas J and Ing T, Little Brown and Company, Boston, 1997 (in
press)
4.Pressman MR, Benz RL: Sleep and Sleep Disorders in
Noncardiopulmonary Medical Disorders. Understanding Sleep - The
Evaluation and Treatment of Sleep Disorders, pp 371-384, Eds.
Pressman MR and Orr WC, American Psychological Association,
Washington, DC, 1997.
3.Benz RL: Chronic Renal Failure. Saunders Manual of Medical
Practice. ed. Rakel. W.B. Saunders, Co., Orlando, FL 1996.
2.Livornese LL, Benz RL, Ingerman MJ, Santoro J: Antibacterial
Agents in Renal Failure. Infectious Disease Clinics of North
America 1995. WB Saunders
1.Benz RL, Teehan BP, Sigler HS, Gilgore GS, Schleifer CR:
Effects of the Osmotic Diuretic Mannitol on Renal Vein Renin
Profiles. Diuretics III, Chemistry, Pharmacology, and Clinical
Applications, pp 20-21, Eds. Puschett J and Greenberg A, Elsevier
Science Publishing Co., Inc., New York, New York 1990.
INVITED LECTURES - INTERNATIONAL
Invited Speaker: Recombinant Human Erythropoietin Therapy in
CRF: Effect on Progression of Renal Failure, Second European
Epoetin Symposium; Optimizing Anemia Therapy in CRF, Crete, Greece,
April 19, 1998.
Expert Panel: How Should Anemia Be Managed in Pre-dialysis
Patients? Second European Epoetin Symposium; (Optimizing Anemia
Therapy in CRF(, Crete, Greece, April 17-19, 1998.
Invited Speaker: Optimum Use of Recombinant Human Erythropoietin
in Predialysis Patients. ( News and Views in Nephrology III.
Australia. May 1995.
Invited Speaker: "The Role of Epoietin Alpha in the Management
of Anemia of Chronic Renal Failure." Philippine Society of
Nephrology. Manila, Philippines, November 16, 1993.
Invited Speaker: "Evaluation and Therapy of Anemia in
Predialysis and Chronic Renal Failure Patients with Recombinant
Human Erythropoietin." Thailand College of Physicians and Thailand
Society of Nephrology. Bangkok, Thailand. November 12, 1993.
Sponsored by Toltzis Communications.
Invited Speaker: "Experimental and Clinical Experience with
Epoietin Alpha in the Anemia of Chronic Renal Failure." Malaysian
Society of Nephrology. Kuala Lumpur, Malaysia, November 10, 1993.
Sponsored by Toltzis Communications.
Invited Speaker: "Experimental and Clinical Experience with
Epoietin Alpha in the Anemia of Chronic Renal Failure." Singapore
Society of Nephrology. Singapore, November 8, 1993. Sponsored by
Toltzis Communications.
Nephrology Grand Rounds: "Treatment of Pre-dialysis Patients
with Epoeitin Alpha: Clinical and Experimental Experience,"
University of Alberta, Edmonton, Alberta, Canada, June 19, 1992
Nephrology Grand Rounds: "Correction of Anemia in Pre-dialysis
Patients with Epoeitin Alpha: Clinical and Experimental
Experience,” Toronto General Hospital, Toronto, Ontario, Canada,
June 12, 1992.
Guest Speaker: "Treatment of Pre-dialysis Patients with Epoeitin
Alpha: Clinical and Experimental Experience," University of British
Columbia, Vancouver, British Columbia, Canada, December 5,
1991.
Guest Speaker: "Update on the Management of Chronic Renal
Failure Patients Utilizing Epoeitin Alpha Therapy," Health Science
Center, Winnipeg, Manitoba, Canada, December 4, 1991.
Guest Speaker: "Does Erythropoietin Therapy Alter the Rate of
Progression of Renal Failure?" Presented at the 5th International
Congress of Metabolism and Nutrition in Renal Disease, Strasbourg,
France. September 1988.
INVITED LECTURES – NATIONAL / REGIONAL
Invited Lecture: American College of Physicians Annual National
Meeting:
April 11 2019: “Acid Base Disorders Diagnosis and
Management”
Television Interview:Regarding Melania Trump procedure for
Kidney lesion NBC 10 News as Issue
May 20 2018
Invited Lecture:“Update on Initiatives of ACGME Internal
Medicine Review Committee” to American Society of Nephrology
Training Program Directors. May 14, 2016 Chicago, IL
Invited Lecture:Renal Grand Rounds at Drexel University
“Evaluation and Management of Hematuria”
April, 2016 Philadelphia Pa.
Invited Speaker:“JNC8 Update – Point/Counterpoint” American
College of Osteopathic Internists Annual Convention and Scientific
Sessions October 1, 2105 Tampa Florida
Invited Speaker:“Physician Engagement in Reducing Cost of
Hospital Care” Presentation on 11% Solution –National Premier Break
Through Meeting, Nashville TN June 14-20, 2011
Invited Speaker:“Approach to Acid Base Disorders” Case
Discussion at Delaware Valley 4th Annual Delaware Valley First
Renal Fellows Summer Symposium Hospital of the University of
Pennsylvania July 6 2011
Invited Speaker:“Approach to Acid Base Disorders” Case
Discussion at Delaware Valley 3rd Annual Delaware Valley First
Renal Fellows Summer Symposium Hospital of the University of
Pennsylvania July 7 2010
Invited Speaker:“Diagnosis and Management of Secondary
Hypertension” American College of Physicians Pri-Med Conference New
York City. Jacob Javitz Convention Center October 5 2010
Invited Speaker:Delaware Valley 2nd Annual Summer Fellow
Symposium; Morrison House, Philadelphia PA, Sponsored by NKF. July
7, 2009. (Acid Base Discussion)
Invited Speaker: Hospital of the University of Pennsylvania and
Presbyterian Hospital Dialysis Staff and Administration,
Philadelphia PA, December 16, 2008. “Update on the Use of
Erythropoiesis Stimulating Agents in Dialysis Patients”.
Invited Speaker:Pottstown Area Dialysis Faculty and Staff,
Rosemont PA, December 10, 2008. “Dynamic Anemia Management”.
Invited Class Speaker: Thomas Jefferson University Medical
College 30th Year Class Reunion, Philadelphia PA, September 27,
2008. “Pathologic Nephrosomnology”.
Invited Speaker: Regional Davita Nephrology Meeting; Media PA.
September 25, 2008.
“Dynamic Anemia Management”.
Invited Speaker: Delaware Valley 1st Annual Summer Fellow
Symposium; Morrison House, Philadelphia PA, Sponsored by NKF. July
8, 2008. (Acid Base and Electrolyte Disturbances)
Invited Speaker: National Dialysis Medical Director’s Meeting
for Fresenius Medical System – North America “Sleepless on Dialysis
– Dialysis Related Sleep Disorders” Tampa FL, April 20, 2007.
Invited Speaker & Chairman: Renal Physicians Association
Satellite Symposium: A Focus on C-Reactive Protein and it’s Role in
Inflammation: Critical Implications for the Dialysis Patient, March
11, 2007, Baltimore MD, RPA National Meeting.
Invited Speaker: Grand Rounds: Recognizing the Association
between Chronic Kidney Disease, Cardiovascular Disease and Anemia,
Taylor Hospital, Ridley Park PA - November 3rd 2005.
Invited Speaker: Grand Rounds: The Relationship Between CKD, CVD
and Anemia(, St. John(s Episcopal Hospital, Far Rockaway, Brooklyn
NY - October 13th 2005.
Invited Speaker: Grand Rounds: Chronic Kidney Disease,
Cardiovascular Disease and Anemia: The Terrible Triad(, Christian
Hospital, St. Louis MO - September 9th 2005.
Invited Speaker: Grand Rounds: Chronic Kidney Disease,
Cardiovascular Disease and Anemia: The Terrible Triad(, Community
General Hospital, Toms River, New Jersey - August 4th 2005.
Invited Speaker: Attaining K/DOQI Guidelines for Anemia: A
Matter of Life or Death, National Kidney Foundation National
Clinical Meeting, Washington DC - May 5th 2005.
Invited Speaker: Pathosomnonephrology- It(s a Lankenau Thing,
Research Colloquium Day - Guest Speaker, Lankenau Institute for
Medical Research Wynnewood PA - March 23rd 2005.
Invited Speaker: Transition from Training to Practice: Finding
Your Niche in Private Practice(, Renal Physicians Association,
Washington DC - March 19th 2005.
Television Interview: Polycystic Kidney Disease( NBC10 News,
November 2005.
Invited Speaker: How Sleep Apnea of End Stage Renal Disease
Differs From Sleep Apnea in the General Population, American
Society of Nephrology, St. Louis MO - October 30th 2004.
Invited Speaker: Sleep Disorders in Renal Patients( Medical
Staff Lecture, Bryn Mawr Hospital, Bryn Mawr PA - June 15th
2004.
Invited Speaker: Sleep Disorders in Renal Patients( Medical
Grand Rounds, Lankenau Hospital, Wynnewood PA - May 14th 2004.
Invited Speaker: EPO Therapy in the Hospitalized Patient: The
Role of Infection and Inflammation( Annual Dialysis Conference
(24th Annual Conference on Peritoneal Dialysis, 10th International
Symposium on Hemodialysis, 15th Annual Symposium on Pediatric
Dialysis), San Antonia TX - February 10th 2004.
Invited Faculty Lecturer: Recognition and Management of
Challenging Patients with ESRD Related Anemia( The National Kidney
Foundation Annual Meeting, Dallas TX - April 3, 2003.
Invited Speaker: Diagnosis and Management of ESRD Patients with
Sub-11 Hemoglobin( Amgen National Medical Advisory Board Meeting,
Laguna Beach CA - February 2003.
Invited Speaker: Sleep Disorders in Dialysis Patients:
Implications and Interventions( Presented to The National Directors
Meeting of Physicians Dialysis, Inc., Naples FL - December
2002.
Invited Presentation: Does Membrane Flux (F) or Dialysis eKT/V
Dose (K) Affect ESRD-Related Sleep Disorders in Hemodialysis (HD)
Patients (Pts)? An Ancillary Study of the HEMO Trial. Presented at
the
National Medical Advisory Board of Renal Care Group, Inc.,
Nashville TN - October 2002.
Oral Presentation: Does Membrane Flux (F) or Dialysis eKT/V Dose
(K) Affect ESRD-Related Sleep Disorders in Hemodialysis (HD)
Patients (Pts)? An Ancillary Study of the HEMO Trial. Presented at
the ASN 35th Annual Meeting, October 30 - November 4, 2002,
Philadelphia, PA.
Invited Speaker: Relationship Between ESRD, Anemia, Sleep
Disorders and Mortality: A Wake-Up Call, Medical Grand Rounds, also
televised statewide on Mountain State TV, Morgantown West Virginia,
April 19, 2002.
Invited Speaker: Sleep Disorders in End Stage Renal Failure,
Renal Grand Rounds, West Virginia University, Morgantown Virginia,
April 18, 2002.
Invited Speaker: Sleep Disorders in End Stage Renal Failure,
Renal Grand Rounds, Winthrop University, Mineola, New York, April
5, 2002.
Invited Speaker: Chronic Renal Failure Management for Primary
Care Physicians, September 17, 2001, Bryn Mawr Hospital, Bryn Mawr,
Pennsylvania.
Invited Speaker: Appropriate Dosing of EPO in Patients with
Anemia of Chronic Renal Failure, October 10, 2001, Meeting of the
Medical Directors of Keystone Independence Blue Cross,
Philadelphia, Pennsylvania.
Invited Speaker: Management of Quality of Life Issues in the
Anemia of Chronic Kidney Disease, July 28, 2001, The Impact of
Anemia on Chronic Kidney Disease Meeting, Philadelphia,
Pennsylvania
Multi-Center Principal Investigator Meeting Recognition,
Diagnosis and Management of Chronic Renal Failure Related Sleep
Disorders, May 12, 2001, Philadelphia, Pennsylvania.
Grand Rounds Baptist Hospital, St. Louis, Missouri: Chronic
Renal Failure and the Primary Care Physician(, February 21, 2001,
St. Louis, Missouri.
National Kidney Foundation of Missouri and the St. Louis Society
for Medical and Scientific Education: (The Anemia of Chronic Renal
Insufficiency: What We Know and How We Know It, February 20, 2001,
St. Louis, Missouri.
University of Virginia Nephrology Symposium: Renal Disease:
Advanced Strategies for Improving Patient Outcomes(, November 4,
2000, Hot Springs, VA.
Consensus Panel on Management of Chronic Renal Insufficiency and
Anemia, ASN, Toronto Canada, October 16, 2000.
American Society of Nephrology Fellowship Mentor Program on
Anemia Management in Renal Failure. October 14, 2000, Toronto,
Canada.
Renal Grand Rounds Speaker: Management of Anemia in Renal
Failure( at Robert Wood Johnson University, New Brunswick, New
Jersey, September 19, 2000.
Invited Panelist: Chronic Renal Insufficiency and Anemia
Advisory Committee, September 16, 2000, New York, NY.
Medical Grand Rounds Speaker: Evaluation and Management of
Hematuria( at Lankenau Hospital, Wynnewood, Pennsylvania, August
25, 2000.
Invited Speaker: Pennsylvania Gambro Medical Directors and
Clinical Managers Annual Educational Meeting in Hershey,
Pennsylvania, July 23, 2000. Management of Anemia in ESRD
Patients
Invited Speaker: Annual Renal Care Group Scientific and
Educational Meeting in Scottsdale, Arizona, May 6, 2000 (Evaluation
and Individualized Therapeutic Approaches to the EPO Hyporesponsive
Patient on Dialysis
Invited Speaker: Satellite Symposium at the National Kidney
Foundation Annual Meeting in Atlanta, Georgia, April 15, 2000
(Diagnosis and Management of the Erythropoietin Hyporesponsive
Anemic Dialysis Patient
Invited Speaker: Advances in Renal Therapy (Advances in Anemia:
Managing the Hyporesponsive Patient( - East Elmhurst NY, March 29,
2000.
Invited Speaker: (Hyporesponse to Erythropoietin Therapy -
Nephrology Fellow Mentorship Program Satellite Sessions at American
Society of Nephrology, Miami Beach, Florida, November 5, 6,
1999.
Invited Speaker: High Blood Pressure: Why We Treat and How We
Treat, Madison House, Philadelphia PA, September 28, 1999.
Invited Speaker: EPO Resistance and Hyporesponse in Dialysis
Patients, AMGEN National Sales Force Annual Meeting, San Diego, CA,
July 1999.
Invited Speaker and Moderator: Concrete Thoughts on ASN
Abstracts - Clinical Nephrology(, Pre-American Society of
Nephrology Program, 31st Annual ASN Scientific Meeting,
Philadelphia, PA, October 23, 1998. (Sponsored by Astra)
Invited Speaker: Hypo-response to Recombinant Human
Erythropoietin Therapy(, Amgen Faculty Meeting, Phoenix, AZ,
November 1997.
Invited Speaker: Why Dialysis Patients Don’t Sleep and Why It
Should Matter to You, National Kidney Foundation of Delaware
Valley, Philadelphia, PA, May 8, 1997.
Invited Speaker: Sleep Disorders, Anemia and Mortality in
End-Stage Renal Failure: Important Inter-relationships, Maurice
Pearl Memorial Lecture, Ochsner Clinic/Tulane/LSU Divisions of
Nephrology, New Orleans, LA, May 5, 1997. Sponsored by the National
Kidney Foundation of Louisiana
Invited Speaker: Management of Renal Osteodystrophy Issues to
Consider, ESRD Network 7, Tampa, FL, December 13, 1996.
Invited Speaker: Renal Osteodystrophy Update, New York Medical
Hospital, Flushing, NY, October 21, 1996.
Invited Speaker: Clinical Correlations Between Sleep, Sleep
Disorders, and Daytime Alertness: Relationship to Correction of
Anemia with Recombinant Human Erythropoietin Therapy, United States
- Japan Joint Conference on Recombinant Human Erythropoietin
Therapy, Oahu, Hawaii, October 9-10, 1996. Sponsored by
Amgen/Kirin.
Invited Speaker: Renal Osteodystrophy: Dosing and Issues of
Adequacy, ESRD Network #11, Detroit, MI, September 13, 1996.
Invited Speaker: Sleep Disorders and Mortality in ESRD Patients,
Abbott Renal Care Medical Advisory Panel, Sonoma, CA August 1,
1996.
Session Moderator: Peritoneal Dialysis - Renal Slide
Presentations, American Society of Artificial Internal Organs, 42nd
Annual Meeting, Washington, D.C. May 2, 1996.
Invited Speaker: Update and Innovations on Renal Osteodystrophy
in End-Stage Renal Failure Patients, Pittsburgh Area Nephrologists,
Pittsburgh, PA April 18, 1996.
Invited Speaker: Correlations in End-Stage Renal Failure
Patients: Sleep Disorders, Anemia and Mortality and the Potential
Impact of r-HuEPO Therapy, Epogen Clinical Grants Investigators(
Symposium, Los Angeles, California. November 30, 1995
Invited Speaker: "Management and Monitoring Therapy of Renal
Osteodystrophy in Dialysis Patients", Western New York Dialysis
Association, Buffalo, NY, November 9, 1994.
Invited Speaker: "Renal Disease in Pregnancy." Dept. of
Obstetrics and Gynecology, Resident Grand Rounds, Lankenau
Hospital, June 17, 1994.
Invited Speaker: "Innovative Concepts in the Monitoring and
Management of Renal Osteodystrophy in Hemodialysis and Peritoneal
Dialysis Patients." Mississippi State Society of Nephrology,
Jackson, Mississippi,
May 14, 1994.
Chairman: Renal Slide Forum and Abstract Presentations. American
Society for Artificial Internal Organs 40th Annual Meeting, San
Francisco, California, April 16, 1994.
Chairman: Panel on "Why Dialysis Patients Can's Sleep and What
You Can Do About It." American Society for Artificial Internal
Organs 40th Annual Meeting, San Francisco, California, April 14,
1994.
Invited Speaker: "Management of Sleep Disorders in End-Stage
Renal Failure Patients." American Society for Artificial Internal
Organs 40th Annual Meeting, San Francisco, California, April 14,
1994. Co-panelist: Paul Kimmel, M.D.
Invited Panelist/Speaker: "Monitoring of Management of Renal
Osteodystrophy with Intravenous Calcitriol Therapy." Renal Care
Advisory Panel. Sponsored by Healthpoint Medical Communication
Associates and Abbott Renal Care. Chicago, IL. April 6, 1994.
Invited Speaker: "Medical Management of Renal Osteodystrophy and
Related Disorders in Hemodialysis and Peritoneal Dialysis
Populations. Long Term Experience." Renal Round Table Focus on
Renal Osteodystrophy, Pearl River, NY, August 13, 1993. Sponsored
by National Medical Care. Co-panelists: Michael Lazarus, M.D., and
James Delmez, M.D.
Invited Speaker: "Renal Osteodystrophy in Dialysis Patients."
National Kidney Foundation, Colorado Springs, CO, May 8, 1993.
Expert Panel Participant, "Sleep Apnea - Mechanical vs
Neurostimulation," American Society of Artificial Internal Organs
39th National Meeting, New Orleans, LA, May 1, 1993.
Session Moderator: "Renal Dialysis Session," American Society of
Artificial Internal Organs 39th National Meeting, New Orleans, LA,
April 30, 1993.
Expert Advisory Panel: "Cost Effectiveness of Intravenous
Calcitriol Therapy in the Treatment of Renal Osteodystrophy,"
Philadelphia, PA, March 5, 1993. Sponsored by Health Technology
Associates. Follow-up meeting, Washington, D.C., June 8, 1993.
Co-panelists: Eduardo Slatopolsky, M.D. and Alan Hillman, M.D.
Invited Speaker: "Clinical Experience with Intravenous
Calcitriol Therapy in Renal Osteodystrophy," Sanibel, FL, March 2,
1993. Abbott Renal Care Symposium.
Invited Speaker: "Clinical Experience and Management of the
Anemia of Chronic Renal Failure with
Recombinant Human Erythropoietin," Dialysis Update for Delaware
Valley Renal Fellows, Philadelphia, PA, February 4, 1993.
Invited Speaker: "Post-Thrombectomy Graft Patency: Same Day vs
Subsequent Day Dialysis," Intercity Kidney Rounds, Thomas Jefferson
University, Philadelphia, PA, February 1, 1993.
Invited Speaker: "Sleep Disorders in End-Stage Renal Failure
Patients," Intercity Kidney Rounds, Thomas Jefferson University,
Philadelphia, PA, February 1, 1993.
Nephrology Grand Rounds: Experimental and Clinical Experience in
the Management of the Anemia of Chronic Renal Failure, Long Island
Medical College Hospital, Brooklyn, NY, December 22, 1992.
Guest Speaker: "Anemia in the Patient with Renal Disease - New
Treatment Update," Biotechnology Symposium, Southern Illinois
University School of Medicine, Memorial Hospital, Springfield, IL,
December 5, 1992.
Chairman, Workshop on "The Use of Recombinant Human
Erythropoietin Therapy in the Anemias of Chronic Renal Failure,
AIDS, and Cancer," Eastern Regional American College of Physicians
Meeting, Philadelphia, PA, October 2, 1992.
Guest Speaker: "Epoetin Alpha Therapy in Patients with Chronic
Renal Failure Not Yet on Dialysis," American Nephrology Nurses
Association, New Jersey Chapter, August 21, 1992.
Guest Speaker: "Physiologic and Quality of Life Effects
Following Correction of Anemia with Epoetin Alpha Therapy in
Patients with Chronic Renal Insufficiency," Epoetin Alpha for the
Treatment of Anemia in Predialysis Patients: Clinical and Quality
of Life Issues Symposium, American Society of Nephrology,
Baltimore, MD, November 19, 1991. Co-panelists: Eli Friedman, M.D.,
Theodore Steinman, M.D. and Brendan P. Teehan, M.D.
Guest Speaker: "Update on the Use of Recombinant Human
Erythropoietin in Dialysis Patients", Kidney Foundation of
Pennsylvania, Penn State College of Medicine, Hershey, PA, April
30, 1991.
Guest Speaker: "Clinical Management of Pre-Dialysis Patients
with Recombinant Human Erythropoietin", Procrit Launch Meeting,
Long Branch, NJ, February 11, 1991.
Guest Speaker: "Renal Anatomy, Physiology, Pathophysiology and
the Management of Chronic Renal Failure", Initial Eprex School for
Ortho-Biotech Product Specialists, Raritan, NJ, November 8,
1990.
Guest Speaker: "Use of Recombinant Human Erythropoietin in
Predialysis Patients", Advances in Nephrology Nursing Symposium,
Robert Woods Johnson University Hospital, New Brunswick, NJ,
October 29, 1990.
Guest Speaker: "Clinical Experience in the Use of Intravenous
Calcitriol,( American Nephrology Nurses Association (Keystone
Chapter), Trevose, PA, September 18, 1990.
Grand Rounds: "Update on Erythropoietin 1990", Medical Center of
Delaware, Christiana Division, Newark, DE, September 6, 1990.
Guest Speaker: "Update on Erythropoietin in ESRD", Kidney
Foundation of Central PA and Penn State College of Medicine,
Hershey, PA, May 10, 1990.
Guest Speaker: "Overview of Clinical and Research Experience
with Epoietin Alpha Therapy", Division of Nephrology, Presbyterian
Medical Center, Philadelphia, PA, April 2, 1990.
Grand Rounds: Clinicopathologic Conference on Goodpasture's
Syndrome, Graduate Hospital, Philadelphia, PA, April 1990.
Guest Speaker: "Anemia of Chronic Renal Failure", Eprex Clinical
Research Associates, Raritan, NJ, January 23, 1990.
Guest Speaker: "Current Clinical Concepts: Evolution of r-HuEPO
in the Anemia of Chronic Renal Failure" at the 24th Annual Meeting
of the American Society of Hospital Pharmacists, Atlanta, Georgia,
December 6, 1989.
Guest Speaker: "Anemia of Chronic Renal Failure: Pathophysiology
and Management", Cilag Clinical Associates and Product Specialists,
Miami, FL, April 6, 1989.
Guest Speaker: "Renal Disease in Pregnancy", Department of
Obstetrics/Gynecology, Lankenau Hospital, February 22, 1988.
Grand Rounds: "What said About NSAIDs and the Kidney", Lankenau
Hospital, Philadelphia, PA, March 20, 1987.
Guest Speaker: "Update on Dialytic Modalities", Medical College
of PA, Philadelphia, PA, July 1986.
Grand Rounds: "NSAID Nephrotoxicity", Riddell Memorial Hospital,
Media, PA, April 1986.
Clinicopathologic Conference Speaker: "Post Streptococcal
Glomerulonephritis", Lankenau Hospital, January 16, 1986.
Grand Rounds: "Update on Diabetic Nephropathy", Montgomery
Hospital, Norristown, PA, May 1985.
Grand Rounds: "Diabetic Nephropathy: Review, Overview, and
Preview", Lankenau Hospital, Philadelphia, PA, March 8, 1985.
Guest Speaker: "Fluid and Electrolyte Balance", National
Intravenous Therapy Association, Philadelphia, PA,
June 19, 1984.
Surgical Grand Rounds: "Acute Renal Failure in the Surgical
Patient", Lankenau Hospital, 1984.
Surgical Grand Rounds: "Nephrology for Surgeons", Lankenau
Hospital, Philadelphia, PA, November 15, 1983.
CLINICAL RESEARCH
2009-2011
Principal Investigator – Treatment of Hyporesponsive Anemia of
Chronic Kidney Disease in Hemodialysis Patients Utilizing
Acetylsteine, Sponsor: Sharpe Foundation
2008
Principal Investigator - Renal Morbidity in Concombinant
Coronary and Renal Angiography
2007
Principal Investigator - A Randomized Placebo-controlled Double
Blinded Study to Evaluate the Long-Term Administration of
Intradialytic Oral Nutritional Supplementation (Pro-Stat) in
Chronic Hemodialysis Patient with Poor Nutritional Status, Sponsor:
Medical Nutrition USA, Inc.
2006
Principal Investigator – A Randomized Open Label, Mulicenter
Study of Epoetin Alfa Comparing Two Extended Dosing Regimens, Once
Weekly and Every Two Weeks, with the Three Times Weekly Dosing
Regimens for Initiation and Maintenance Treatment in Anemic
Subjects with Chronic Kidney Disease, Sponsor: Johnson &
Johnson Pharmaceutical Research and Development
2005
Principal Investigator - An Open-Label, Randomized, Multicenter
Study of the Initiation of Four Dosing Regimens of Procrit (Epoetin
Alfa) for the Treatment of Anemia of Chronic Kidney Disease (CKD),
Sponsor: Ortho Biotech
2005
Principal Investigator - A Muticenter, Observational Registry of
Subjects with Secondary Hyperparathyroidism (HPT) and Chronic
Kidney Disease (CKD). Sponsor: Amgen
2005
Principal Investigator - A Double-Blind, Cross-Over Design Study
of Sevelamer Hydrochloride (Renagel) and Sevelamer Carbonate in
Chronic Kidney Disease Patient on Hemodialysis
Sponsor: Genzyme Corporation
2005
Principal Investigator - A Randomized Double Blind Placebo
Controlled Study to Assess the Efficacy and Safety of Cinacalcet
HCL in Chronic Kidney Disease (CKD) Subject with Secondary
Hyperparathyroidism Not Receiving Dialysis, Sponsor: Amgen
2003
Principal Investigator - Aranesp African-American Hemodialysis
Study (A Randomized Double-Blind Study comparing Aranesp and EPO in
the Treatment of Anemia in African-American Subject with CRF)
Protocol 20010125, Sponsor: Amgen, Inc.
2003
Principal Investigator - The STAAR Study (A Multi-Center Study
Using Once Every Other Week Subcutaneous Administration of Aranesp
(darbepoetin alfa) and Iron Guarded Algorhythms to Treat Subjects
with Anemia of Chronic Renal Insufficiency) Protocol 20010215
Sponsor: Amgen, Inc.
2003
Principal Investigator - PROMPT Study (A Randomized Open Label
Clinical Evaluation of Epoetin Alfa for Maintenance Phase Treatment
of Patients with Anemia due to Chronic Kidney Disease) Protocol
PR01-06021 Sponsor: Ortho Biotech
2002
Principal Investigator - READ Study (Single Site Study on
Retrospective Study on Effect of Acetylcysteine in the Prevention
of Dye Nephropathy following Cardiac Catheterization) F/N-R03-2026L
Self-Sponsored
2001
Principal Investigator - (A Pilot Study to Assess the Impact of
Anemia Correction with Novel Erythropoiesis Stimulating Protein
(NESP) on Sleep Disorders Associated with Chronic Renal
Insufficiency (CRI)( Protocol 20000195, Sponsor: Amgen, Inc.
2001
Principal Investigator - Renal Anemia Management Project
Sponsor: Renal Care Group, Inc. and Amgen, Inc
2001
Principal Investigator - A Study Evaluating the Initiation of
Fixed Doses of Novel Erythropoiesis Stimulating Protein (NESP)
Therapy in Subject with Chronic Renal Insufficiency (CRI)( Protocol
990788. Sponsor: Amgen, Inc.
2001
Principal Investigator - Phase II Study - A Randomized
Double-Blind, Placebo-Controlled Study to Assess the Efficacy and
Safety of an Oral Calcimimetic Agent (AMG-073) in Secondary
Hyperparathyroidism of Chronic Renal Insufficiency
Protocol AMG073-20000236 Sponsor: Amgen, Inc.
2001
Principal Investigator - A Randomized Double-Blind,
Placebo-Controlled Study to Assess the Efficacy and Safety of an
Oral Calcimimetic Agent (AMG-073) in Secondary Hyperparathyroidism
of Chronic Renal Failure, Protocol AMG073-20000237, Sponsor: Amgen,
Inc.
2000
Principal Investigator - Effects of Hemodialysis Dose on End
Stage Renal Disease Related Sleep Disorders (The Sleepo Study)
supported by the John S. Sharpe Research Foundation.
1999
Principal Investigator - Phase II Study (A Double-Blind,
Randomized, Placebo-Controlled, Multi Center Study to Assess the
Safety and Efficacy of an Oral Calcimimetic Agent (AMG 073) in
Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
Allowing Dose Adjustments in Vitamin D Analog Concomitant Therapy.
Protocol #990740 Sponsor: Amgen, Inc.
1998-1999Principal Investigator - A Randomized, Double-Blind,
Non-Inferiority Study of IV Novel Erythropoiesis Stimulating
Protein (NESP) Compared to IV Recombinant Human Erythropoietin
(r-HuEPO) for Treatment of Anemia in Patients with End-Stage Renal
Disease (ESRD) Receiving Hemodialysis. Sponsor: Amgen, Inc.
1995-1998Predicting Mortality in ESRD Patients with Sleep
Disorders(
1995-
Principal Investigator - Phase II Study: Multidose Evaluation of
19-nor-1 alpha, 25-dihydroxyvitamind D2 in End-Stage Renal Disease
Patients Undergoing Dialysis
Sponsor: Abbott Laboratories (protocol 95022)
1995-1997Principal Investigator - Effect of Dialysis Regimens on
Sleep Disorders in
Hemodialysis Patients.
Sponsor: National Institutes of Health, U.S. Public Health
Service (RO-1 submitted to NIH - not yet funded)
1994-2001Co-Principal Investigator - Hemodialysis Efficiency,
Membranes and Outcome(
(HEMO Study). Sponsor: National Institutes of Health, U.S.
Public Health Service
1994-1995Co-Investigator, " An Open-label Randomized Study to
Compare the Safety and Efficacy of TIW vs Weekly Subcutaneous
Dosing of PROCRIT (Epoetin Alfa) for the Anemia of Chronic Renal
Failure in Predialysis Subjects." Sponsor: Ortho Biotech
1993-1994Principal Investigator, "Plasma Lipid Fatty Acid
Profiles in Maintenance Hemodialysis Patients: Effects of Linoleic
Acid Supplement." (Co-investigator with Charles Skutches, Ph.D.,
Lankenau Medical Research Center)
1994-1997Principal Investigator, "The Effects of Normal vs
Anemic Hematocrit on Outcomes
of Cardiac Disease in Dialysis Patients." Multi-Center Trial
Sponsor: Amgen
1993-1995Investigator, (Evaluation of the Mini-Clinical
Evaluation Examination Format in Medical Education. American Board
of Internal Medicine
1993-1995Co-Investigator, "Effect of Lactobacillus Acidophilus
on Appetite in Dialysis Patients." Multi-Center Study with Michael
Simenhoff
(Thomas Jefferson University).
1993-1995Principal Investigator, "Relationship Between Anemia of
Chronic Renal Failure and Sleep, Sleep Disorders and Daytime
Alertness: Benefits of Correction of Anemia with rHU-EPO in
Patients on Dialysis" (EPO-92-030) Sponsor: Amgen
1993-1994Co-Investigator, "The Effect of r-HuEPO (Manati) on the
Anemia of Chronic Failure in Pre-dialysis Patients" (M92-056)
Sponsor: Robert Wood Johnson Pharmaceutical Research Institute
(Ortho Biotech)
1990-1993Investigator, National Cooperative rHu Erythropoietin
Study in Patients with Chronic Renal Failure: A Phase IV
Multi-Center Study Protocol #EPO-8903 Sponsor: Amgen
1989
Co-Principal Investigator, "Renal Function in Chronic Renal
Failure Pre-Dialysis Patients Receiving Recombinant Human
Erythropoietin Therapy for the Anemia of Chronic Renal
Insufficiency"
Sponsor: R.W.Johnson Pharmaceutical Research Institute (Ortho
Biotech)
1987
Co-Investigator: Hematologic and Physiologic Effects of
Recombinant Human Erythropoietin in Predialysis Patients. Sponsor:
Robert Wood Johnson Pharmaceutical Research Institute
(Ortho Biotech)
